An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma
- DOI
- 10.2217/cns-2022-0016
- Published
- 2023-07-18
- Container
- CNS Oncology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2217/cns-2022-0016,
title = {An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma},
author = {Garni Barkhoudarian and Michael Badruddoja and Nicholas Blondin and Sajeel Chowdhary and Charles Cobbs and Julius Paul Duic and John Paul Flores and Ekokobe Fonkem and Edward McClay and Louis Burt Nabors and Michael Salacz and Lynn Taylor and Brian Vaillant and Jaya Gill and Santosh Kesari},
year = {2023},
journal = {CNS Oncology},
doi = {10.2217/cns-2022-0016},
url = {https://doi.org/10.2217/cns-2022-0016}
}RIS
TY - JOUR TI - An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma AU - Garni Barkhoudarian AU - Michael Badruddoja AU - Nicholas Blondin AU - Sajeel Chowdhary AU - Charles Cobbs AU - Julius Paul Duic AU - John Paul Flores AU - Ekokobe Fonkem AU - Edward McClay AU - Louis Burt Nabors AU - Michael Salacz AU - Lynn Taylor AU - Brian Vaillant AU - Jaya Gill AU - Santosh Kesari PY - 2023 JO - CNS Oncology DO - 10.2217/cns-2022-0016 UR - https://doi.org/10.2217/cns-2022-0016 ER -
APA
Barkhoudarian, G., Badruddoja, M., Blondin, N., Chowdhary, S., Cobbs, C., Duic, J. P., Flores, J. P., Fonkem, E., McClay, E., Nabors, L. B., Salacz, M., Taylor, L., Vaillant, B., Gill, J., & Kesari, S. (2023). An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma. CNS Oncology. https://doi.org/10.2217/cns-2022-0016
Source records
- crossref · retrieved 2026-09-26T13:31:14.084Z